MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor

Source: PRNewswire· August 12, 2026

GENEVA, Aug. 12, 2026 /PRNewswire/ -- MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. John Krakauer has joined the Company as a strategic ad…

This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire

More in Products & Launches

View all